4.8 Article

L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis

Journal

CELL REPORTS
Volume 38, Issue 11, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2022.110507

Keywords

-

Categories

Funding

  1. National Institutes of Health [R01-AI104732, R21EB030171, R01 AI118719, HL148033, R01AI139540, R56 AI104732]
  2. National Science Foundation [CBET-1900277, CMMI1548571]
  3. American Lung Association [ETRA 736343]
  4. Washington University in Saint Louis Children's Discovery Institute grants [CDI-CORE-2019-813, CDI-CORE-2015-505]
  5. Foundation for Barnes-Jewish Hospital grants [3770, 4642]
  6. American Association of Immunologists AAI Careers in immunology fellowship

Ask authors/readers for more resources

The actin-bundling protein L-plastin (LPL) plays a crucial role in the activation of the NLRP3 inflammasome, which is involved in IL-1 beta production. LPL stabilizes the interactions between ASC and the kinase Pyk2, enabling ASC oligomerization during NLRP3 assembly.
Macrophage adhesion and stretching have been shown to induce interleukin (IL)-1 beta production, but the mechanism of this mechanotransduction remains unclear. Here we specify the molecular link between mechanical tension on tissue-resident macrophages and activation of the NLRP3 inflammasome, which governs IL-1 beta production. NLRP3 activation enhances antimicrobial defense, but excessive NLRP3 activity causes inflammatory tissue damage in conditions such as pulmonary fibrosis and acute respiratory distress syndrome. We find that the actin-bundling protein L-plastin (LPL) significantly enhances NLRP3 assembly. Specifically, LPL enables apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) oligomerization during NLRP3 assembly by stabilizing ASC interactions with the kinase Pyk2, a component of cell-surface adhesive structures called podosomes. Upon treatment with exogenous NLRP3 activators, lung-resident alveolar macrophages (AMs) lacking LPL exhibit reduced caspase-1 activity, IL-1 beta cleavage, and gasdermin-D processing. LPL-/- mice display resistance to bleo- mycin-induced lung injury and fibrosis. These findings identify the LPL-Pyk2-ASC pathway as a target for modulation in NLRP3-mediated inflammatory conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available